AF
REGN icon

Allworth Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Allworth Financial’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Sell
2,530
-461
-15% -$314K 0.01% 587
2026
Q1 		$2.31M Buy
2,991
+808
+37% +$619K 0.01% 501
2025
Q4 		$1.69M Buy
2,183
+687
+46% +$467K 0.01% 557
2025
Q3 		$841K Buy
1,496
+502
+51% +$284K ﹤0.01% 715
2025
Q2 		$522K Buy
994
+173
+21% +$96.6K ﹤0.01% 834
2025
Q1 		$493K Sell
821
-137
-14% -$94.2K ﹤0.01% 687
2024
Q4 		$651K Buy
958
+249
+35% +$209K ﹤0.01% 626
2024
Q3 		$745K Buy
709
+48
+7% +$53.4K ﹤0.01% 494
2024
Q2 		$703K Buy
661
+133
+25% +$129K ﹤0.01% 491
2024
Q1 		$508K Buy
528
+166
+46% +$158K ﹤0.01% 542
2023
Q4 		$318K Buy
362
+4
+1% +$3.29K ﹤0.01% 629
2023
Q3 		$295K Buy
358
+16
+5% +$12.6K ﹤0.01% 608
2023
Q2 		$246K Buy
342
+179
+110% +$138K ﹤0.01% 646
2023
Q1 		$134K Buy
163
+24
+17% +$18.1K ﹤0.01% 756
2022
Q4 		$100K Buy
139
+10
+8% +$7.38K ﹤0.01% 815
2022
Q3 		$89K Buy
129
+37
+40% +$23.3K ﹤0.01% 800
2022
Q2 		$54K Buy
92
+45
+96% +$29.3K ﹤0.01% 881
2022
Q1 		$33K Sell
47
-8
-15% -$5.06K ﹤0.01% 1042
2021
Q4 		$35K Buy
55
+23
+72% +$14.1K ﹤0.01% 936
2021
Q3 		$19K Buy
+32
New +$19.9K ﹤0.01% 1061
2021
Q2 		– Sell
-36
Closed -$17K – 1646
2021
Q1 		$17K Hold
36
– – ﹤0.01% 837
2020
Q4 		$17K Hold
36
– – ﹤0.01% 710
2020
Q3 		$20K Hold
36
– – ﹤0.01% 570
2020
Q2 		$22K Buy
+36
New +$20.4K ﹤0.01% 572
2017
Q2 		– Sell
-4
Closed -$2K – 809
2017
Q1 		$2K Buy
+4
New +$1.48K ﹤0.01% 660

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Allworth Financial's REGN Position: Q2 2026 in Review

Allworth Financial reduced its Regeneron Pharmaceuticals (REGN) stake by 15% in Q2 2026, selling an estimated $314K and leaving 2,530 shares worth $1.58M. The position accounts for 0.01% of the portfolio, ranked #587.

Allworth Financial first reported a position in REGN in Q1 2017 and has held it in 25 quarters since. The position peaked at $2.31M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Allworth Financial held 2,530 shares of Regeneron Pharmaceuticals worth $1.58M as of Q2 2026.
  • Allworth Financial sold 461 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $314K.
  • Regeneron Pharmaceuticals made up 0.01% of Allworth Financial's portfolio in Q2 2026, its #587 holding.
  • Allworth Financial first reported a position in Regeneron Pharmaceuticals in Q1 2017 and has held it in 25 quarters since.
  • Allworth Financial's Regeneron Pharmaceuticals position peaked at $2.31M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.